Clinical and molecular characterization of SLC31A1-related developmental and epileptic encephalopathy: insights from 13 new cases
Natalia Juliá‐Palacios(Hospital Sant Joan de Déu Barcelona), Roser Urreizti(Red de Investigación en Actividades Preventivas y Promoción de la Salud), Christopher J. Carroll(St George's, University of London), Mar O’Callaghan(Western University), Klaas J. Wierenga(Mayo Clinic in Florida), Jordi Muchart-López(Hospital Sant Joan de Déu Barcelona), Janet Hoenicka(Hospital Sant Joan de Déu Barcelona), Ingrid Cristian(Arnold Palmer Hospital for Children), Rafael Artuch(Instituto de Investigación de Enfermedades Raras), Seyed Hassan Tonekaboni(Shahid Beheshti University of Medical Sciences), Frederic Tort(Instituto de Salud Carlos III), Huma Arshad Cheema(University of Health Sciences Lahore), Gerard Muñoz‐Pujol(Centre for Biomedical Network Research on Rare Diseases), Patrick M. Gaffney(Oklahoma Medical Research Foundation), Abraham J. Paredes‐Fuentes(Hospital Clínic de Barcelona), Bryn D. Webb(Child Health and Development Institute), Juan Darío Ortigoza‐Escobar(Instituto de Salud Carlos III), Irene Machado-Casas(Instituto de Investigación Biosanitaria de Granada), Marwa Abd Elmaksoud(Alexandria University), Jennifer Morrison(Arnold Palmer Hospital for Children), Nouriya Al‐Sannaa(Saudi Aramco Medical Services Organization), Àngels García‐Cazorla(Areté Associates (United States)), Antònia Ribes(Instituto de Salud Carlos III), Aida M. Bertoli‐Avella(Centogene (Germany)), Mohammad Miryounesi(Shahid Beheshti University of Medical Sciences), Henry Houlden(Queen Mary University of London), Reza Maroofian(University College London), Carlos Santos‐Ocaña(Instituto de Salud Carlos III), Francesc Palau(Hospital Sant Joan de Déu Barcelona), Heidy Baide‐Mairena(Universitat Autònoma de Barcelona), Sahar Alijanpour(Shahid Beheshti University of Medical Sciences), Emir Zonic(Centogene (Germany)), Peter Bauer(Centogene (Germany)), Muhammad Nadeem Anjum(University of Health Sciences Lahore), Anna Codina(Centro de Investigación Biomédica en Red), Faroug Ababneh(King Saud bin Abdulaziz University for Health Sciences), Maria Urbaniak(Hospital Sant Joan de Déu Barcelona), Afshin Fayazi(Hamedan University of Medical Sciences), Uxía Barba(Hospital Sant Joan de Déu Barcelona), Marta Gómez‐Chiari(Hospital Sant Joan de Déu Barcelona)
Cited by 4
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
|Nature Genetics|2019|592
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
|Journal of Clinical Investigation|2011|402
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386